Cargando…
Iclaprim reduces the incidence and severity of Staphylococcus aureus-induced septic arthritis in a murine model
Staphylococcus aureus is the most common non-gonococcal aetiology of septic arthritis. The efficacy of iclaprim against S. aureus LS-1, a clinical strain identified from a patient with septic arthritis, was studied in MF1 mice to evaluate the activity of iclaprim, which is in clinical development, i...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Microbiology Society
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481738/ https://www.ncbi.nlm.nih.gov/pubmed/32974543 http://dx.doi.org/10.1099/acmi.0.000052 |